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Predictors of surgical site infection after open
lower extremity revascularization
David Yu Greenblatt, MD, MSPH,a Victoria Rajamanickam, MS,a and Matthew W. Mell, MD,b Madison,
Wisc; and Stanford, Calif
Objectives: Surgical site infection (SSI) after open surgery for lower extremity revascularization is a serious complication
that may lead to graft infection, prolonged hospitalization, and increased cost. Rates of SSI after revascularization vary
widely, with most studies reported from single institutions. The objective of this study was to describe the rate and
predictors of SSI after surgery for arterial occlusive disease using national data, and to identify any association between
SSI and length of hospital stay, reoperation, graft loss, and mortality.
Methods: Patients who underwent lower extremity arterial bypass or thromboendarterectomy from 2005-2008 were
identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)
participant use files. Multivariate logistic regression identified predictors of SSI. Odds ratios were adjusted for patient
demographics, comorbidities, preoperative laboratory values, and operative factors. The association between SSI and
other 30-day outcomes such as mortality and graft failure was determined.
Results:Of 12,330 patients who underwent revascularization, 1367 (11.1%) were diagnosed with an SSI within 30 days.
Multivariate predictors of SSI included female gender (odds ratio [OR], 1.4; 95% confidence interval [CI], 1.3-1.6),
obesity (OR, 2.1; 95% CI, 1.8-2.4), chronic obstructive pulmonary disease (OR, 1.2; 95% CI, 1.0-1.5), dialysis (OR, 1.5;
95% CI, 1.1-2.1), preoperative hyponatremia (OR, 1.2; 95% CI, 1.0-1.4), and length of operation >4 hours (OR, 1.4;
95%CI, 1.2-1.6). SSI was associated with prolonged (>10 days) hospital stay (OR, 1.8; 95%CI, 1.4-2.1) and higher rates
of 30-day graft loss (OR, 2.3; 95% CI, 1.7-3.1) and reoperation (OR, 3.7; 95% CI, 3.1-4.6). SSI was not associated with
increased 30-day mortality.
Conclusion: SSI is a common complication after open revascularization and is associated with a more than twofold
increased risk of early graft loss and reoperation. Several patient and operation-related risk factors that predict
postoperative SSI were identified, suggesting that targeted improvements in perioperative care may decrease complica-
tions and improve outcomes in this patient population. (J Vasc Surg 2011;54:433-9.)
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dSurgical site infection (SSI) after reconstruction for
lower extremity arterial occlusive disease is a serious com-
plication that leads to patient morbidity, prolonged length
of stay, increased healthcare expenditures, graft failure, and
limb loss. Numerous studies have reported risk factors for
SSI after vascular surgery,1-10 but few have utilized national
data. We addressed this gap in the literature by analyzing
the multi-institutional American College of Surgeons Na-
tional Surgical Quality Improvement Project (ACS-
NSQIP) database. The study results provide insight into
the frequency, contributing factors, and consequences of
wound infection after lower extremity revascularization.
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Data acquisition and patient selection. The ACS-
SQIP provides risk-adjusted outcomes data to participat-
ng hospitals for the purpose of quality improvement. The
rogram focuses on 30-day postoperative outcomes, in-
luding mortality and 21 categories of morbidity. Data
ollection at each participating institution is performed by a
edicated surgical clinical reviewer (SCR), with support
nd oversight from a nurse coordinator. The SCR, using
edical chart extraction, 30-day interviews, and other
ethods, collects detailed data on patient demographics,
omorbidities, laboratory values, operative variables, and
ostoperative outcomes, including 30-day complications,
0-day mortality rates, reoperation, and length of stay.
escriptions of the qualifications, training, and auditing of
ata collection personnel, case inclusion criteria, sampling
nd data collection strategy, and variable and outcome
efinitions are available online from the ACS-NSQIP Web
ite.11
Patients who underwent open bypass or thromboen-
arterectomy for infrainguinal occlusive disease were iden-
ified from the 2005-2008 ACS-NSQIP participant use
les, which include data collected from 211 academic and
ommunity hospitals throughout the United States, using
urrent procedural terminology codes.
Outcomes. The main outcome was SSI within 30-
ays of open revascularization. We defined SSI as a com-
osite of the following ACS-NSQIP variables: superficial
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August 2011434 Greenblatt et alSSI, deep SSI, organ/space SSI, and dehiscence (defined as
separation of the layers of a surgical wound with disruption
of the fascia within 30 days of the operation). Additional
postoperative outcomes included reoperation, length of
hospital stay (LOS) after surgery, 30-day graft failure, and
30-day mortality.
Explanatory and control variables. Independent
variables included demographics, preoperative health status
and comorbidities, preoperative laboratory values, and op-
erative factors. Demographics consisted of age, gender, and
race (white, black, or other). Variables related to preoper-
ative health included functional status (independent vs
totally or partially dependent), body mass index, weight
loss (10% of total body weight in 6 months), smoking (in
the last year), alcohol use (more than two drinks per day in
the 2 weeks prior to surgery), corticosteroid use, and recent
blood transfusion or operation. Factors related to periph-
eral vascular disease (PVD) included history of revascular-
ization or amputation for PVD and critical limb ischemia
(rest pain or gangrene). Comorbidities included diabetes
mellitus, chronic obstructive pulmonary disease (COPD),
coronary artery disease (history of angina, myocardial in-
farction, previous percutaneous cardiac intervention, or
previous cardiac surgery), neurologic disease (history of
stroke with or without residual deficit, transient ischemic
attack, hemiplegia, paraplegia, or quadriplegia, central ner-
vous system tumor, or impaired sensorium), dyspnea,
pneumonia, congestive heart failure, disseminated cancer,
chemotherapy (within 30 days prior to surgery), radiation
therapy (within 90 days prior to surgery), and bleeding
disorder. Operative variables included wound class, Amer-
ican Society of Anesthesiologists (ASA) class, number of
blood transfusions, and length of operation.
Preoperative laboratory values consisted of white blood
cell count, hematocrit, platelet count, international nor-
malized ratio (INR), sodium, blood urea nitrogen, creati-
nine, and albumin. The standard ACS-NSQIP definitions
of abnormal values for several laboratory variables were
problematic when applied to our study population. For
example, over 51% of the patients in the sample had hemat-
ocrit values38%, the lower limit of normal for hematocrit
in the standard ACS-NSQIP definition. Therefore, we an-
alyzed the distribution of preoperative laboratory values in
the study population and defined laboratory value catego-
ries based on percentiles. Each categorical laboratory vari-
able included an indicator of missing data. This approach
was supported over alternative methods such as single or
multiple imputation by a study on missing data in ACS-
NSQIP, which demonstrated that missing laboratory val-
ues are not missing at random in this database.12 Variables
with over 5% missing values in the analysis sample included
albumin (52% missing), INR (17% missing), and BUN (6%
missing).
Statistical analysis. The frequencies of the indepen-
dent and dependent variables were determined in three
groups: all patients, those without a 30-day postoperative
SSI, and those with a 30-day postoperative SSI. Continu-
ous variables were compared using the Wilcoxon rank-sum west or Mann–Whitney U test, and categorical variables
ith 2 tests. All variables with P values .05 were eligible
or inclusion in multivariate models for SSI. To avoid
ulticollinearity, only one variable was included from each
et of intercorrelated variables when the Pearson coefficient
as greater than 0.3 (or less than 0.3). Multivariate
ogistic regression was utilized to calculate adjusted odds
atios and 95% confidence intervals (CIs) for 30-day SSI.
nalyses were performed using SAS 9.1.3 for Windows
SAS Institute, Cary, NC). All tests of significance were at
he P  .05 level, and P values were two-tailed.
ESULTS
Patient characteristics. The study population con-
isted of 12,330 patients who underwent open surgery for
ower extremity PVD. The mean age was 68 years, and 37%
ere female. Approximately 74% were white, 15% were
lack, and 12% another race. Themajority (54%) of patients
ad a history of prior revascularization or amputation for
VD, and 46% had critical limb ischemia. Almost one-third
33%) of the patients had an open or infected wound before
urgery. The prevalence of smoking was 42%. Approxi-
ately 18% had nonindependent functional status. The
requencies of obesity, diabetes, hypertension, and coro-
ary artery disease were 28%, 7%, 83%, and 39%, respec-
ively. Approximately 7% had a prior operation within 30
ays.
Of 12,330 patients who underwent open revasculariza-
ion, 1367 (11.1%) were diagnosed with an SSI within 30
ays. The differences between patients that did not have
SI and those who did are shown in Table I. The SSI group
as younger, more predominantly female, had a higher
requency of critical limb ischemia, and a history of prior
evascularization or amputation for PVD. Approximately
3% of the SSI group had nonindependent functional
tatus, compared with 18% in the no-SSI group (P .001).
he prevalence of the following comorbid conditions was
igher in the SSI group: obesity, diabetes, dyspnea, COPD,
oronary artery disease, hypertension, neurologic disease,
ialysis, corticosteroid use, open or infected wound, and
epsis. There was no difference between the two groups in
he use of tobacco or alcohol or in the frequency of preop-
rative congestive heart failure, acute renal failure, bleeding
isorder, pneumonia, disseminated cancer, recent do not
esuscitate (DNR) order, or prior operation within the past
0 days.
The group diagnosed with SSI had a higher frequency
f abnormally high (90th percentile) preoperative creat-
nine and abnormally low (10th percentile) sodium and
lbumin. There were no differences in preoperative values
f WBC count, hematocrit, platelet count, INR, or BUN.
The SSI group had a higher ASA class, more intraop-
rative blood transfusions, and a longer mean length of
peration (242 min vs 214 min, P  .001). Wound con-
amination classification was equivalent between the two
roups.
Predictors of SSI. The independent variables that
ere associated with SSI at the P  .05 level in univariate
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Volume 54, Number 2 Greenblatt et al 435Table I. Univariate assessment of factors associated with surgical site infection (SSI) in 12,330 patients who underwent
open lower extremity revascularization
Characteristic
No SSI
n  10,963 (88.9%)
SSI
n  1367 (11.1%) P value
Demographics
Age (years), mean (SD) 67.9  12.0 66.8  12.0 .001a
Female gender 35.8% 44.0% .001a
Race/ethnicity .747
White 73.8% 73.3%
Black 14.5% 15.3%
Other 11.7% 11.4%
Preoperative health and comorbidities
Rest pain or gangrene 45.1% 53.3% .001a
History of revascularization or amputation 53.0% 57.2% .004a
Current smoker 41.7% 42.0% .816
Alcohol use (2 drinks per day) 6.2% 5.3% .207
Functional status: partially or totally dependent 17.5% 22.7% .001a
BMI (kg/m2), mean (SD) 27.0  6.1 29.2  6.9 .001a
Recent weight loss 1.7% 1.8% .824
Diabetes mellitus 39.2% 48.1% .001a
Dyspnea 19.2% 22.4% .005a
COPD 13.3% 15.7% .021a
Coronary artery disease 38.7% 42.4% .010a
Congestive heart failure 3.0% 3.7% .133
Hypertension requiring medication 82.8% 86.8% .000a
Neurologic disease or event 19.7% 22.4% .018a
Acute renal failure 1.4% 2.1% .052
Dialysis 6.2% 9.4% .001a
Steroids 4.1% 5.3% .046a
Bleeding disorder 23.3% 25.3% .097
Open or infected wound 32.4% 38.8% .001a
Pneumonia 0.5% 0.2% .277
Sepsis 6.3% 8.7% .001a
Disseminated cancer 0.6% 0.3% .315
Chemo or radiation therapy 0.7% 0.4% .374
DNR order 1.1% 0.9% .576
Prior operation within 30 days 7.2% 8.3% .156
Preoperative laboratory values
WBC count  12.2 cells/mm3 (90th percentile) 9.4% 11.3% .085
Hematocrit  29.5 % (10th percentile) 9.4% 10.7% .274
Platelet count, cells/mm3 .228
156 (10th percentile) 9.6% 9.9%
388 (90th percentile) 9.4% 11.1%
INR  1.3 (90th percentile) 8.3% 8.3% .447
Sodium, mmol/L .016a
134 (10th percentile) 12.3% 15.3%
142 (90th percentile) 7.6% 7.5%
BUN  37 mg/dL (90th percentile) 8.7% 10.0% .254
Creatinine  2.1 mg/dL (90th percentile) 9.2% 11.7% .013a
Albumin  2.6 mg/dL (10th percentile) 4.0% 5.4% .024a
Operative variables
Procedure .001a
Endarterectomy 14.8% 11.6%
Femoral to femoral bypass 11.1% 8.9%
Femoral to popliteal bypass 42.4% 43.0%
Femoral to tibial vessel bypass 24.8% 28.2%
Popliteal to tibial vessel bypass 7.0% 8.3%
Type of bypass graft .001a
None (thromboendarterectomy) 14.8% 11.6%
Reversed vein 43.4% 46.0%
In situ vein 9.4% 12.6%
Prosthetic 32.4% 29.8%
Wound class .081
Clean or clean-contaminated 92.3% 90.6%
Contaminated 4.3% 5.4%
Dirty or infected 3.4% 4.0%
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August 2011436 Greenblatt et alanalysis were used to construct a multivariate model. Lo-
gistic regression was utilized to calculate adjusted odds
ratios and 95% CIs for SSI. The results of this analysis are
displayed in Table II. After adjusting for other variables, the
significant predictors of SSI consisted of female gender
(OR, 1.44; 95% CI, 1.28-1.63), overweight (OR, 1.28;
95% CI, 1.10-1.49), obesity (OR, 2.08; 95% CI, 1.78-
2.43), COPD (OR, 1.23; 95% CI, 1.03-1.44), dialysis
(OR, 1.51; 95%CI, 1.08-2.11), hyponatremia (134mg/
dL; OR, 1.20; 95% CI, 1.02-1.42), and length of operation
4 hours (OR, 1.42; 95% CI 1.24-1.63).
Association between SSI and LOS, reoperation,
and graft failure. The SSI group had a higher frequency
of prolonged LOS (22.8% vs 12.2%), reoperation (40.2% vs
15.0%), and 30-day graft failure (10.8% vs 4.7%). These
differences were all highly statistically significant (P 
.001). After adjusting for potential confounders, the pre-
dicted probabilities of these adverse outcomes were still
significantly different between the two groups (Table III).
We were not able to determine the reason for reoperation
using NSQIP data.
Association between SSI and 30-day mortality. SSI
was associated with decreased 30-day mortality (1.6% vs
2.9%, P  .005). In a multivariate model, the adjusted
predicted probability of 30-day mortality in patients who
had SSI was 1.6% (95% CI, 1.5%-1.8%), compared with
2.7% (95% CI, 2.6%-2.8%) in those who did not have the
complication (Table III). Further analysis revealed an in-
teraction between age, SSI, and mortality. For patients less
than age 80, there was no significant association between
SSI and mortality. For those 80 and older, however, the
rate of 30-day mortality was lower in patients who did have
SSI compared with those who did not (1.4% vs 5.8%, P 
.003). In this age group, 218 of 2256 patients were diag-
nosed with SSI, and the median number of days from
surgery until diagnosis was 15. Of the 2256 patients aged
80 or older, 112 died within 30 days, and themedian day of
death was 13. When patients aged 80 and older were
excluded from the cohort, there was no significant associ-
Table I. Continued
Characteristic n
ASA class
No or mild disturbance
Severe disturbance
Life-threatening disturbance or moribund
Blood transfusions
None
1-2 units
3 or more
Length of operation (min), mean (SD)
Emergency operation
Work relative value units, mean (SD)
ASA, American Society of Anesthesiologists; BMI, body mass index; BUN, b
resuscitate; INR, international Normalized Ratio; SD, standard deviation; W
aStatistically significant at the P  .05 level.ation between SSI and mortality. sISCUSSION
In this study based on the multi-institutional ACS-
SQIP database, we determined the rate, predictors, and
onsequences of SSI in a real-world experience of patients
ndergoing open lower extremity revascularization sur-
ery. In the current study, independent predictors of SSI
ncluded patient factors (female gender, critical limb isch-
mia, obesity and overweight, COPD, dialysis, preopera-
ive hyponatremia) and operation time 4 hours.
Other investigators have noted the association between
rolonged operative time and SSI, underscoring the impor-
ance of minimizing operative time when possible.6,13 For
ong operations, factors that may underlie the association
ith SSI include patient hypothermia,14 hyperglycemia,15
nadequate redoing of antibiotics,16 retractor-related tissue
rauma, and breaks in sterile technique. Targeting these
actors may provide important strategies for decreasing the
ate of SSI after long operations and improving out-
omes.17 Attention to these factors may be particularly
mportant for complex reconstructions for which long op-
rative times can be anticipated.
Female gender,8,18-21 obesity,3,4,21,22 and renal failure
equiring dialysis5,23,24 are well-described risk factors for
SI and other adverse outcomes after peripheral vascular
urgery. Potential explanations for the link between female
ender and increased infrainguinal wound infections in-
lude gender-related differences in the amount and distri-
ution of body fat and native skin flora.8 Greater thickness
f poorly vascularized subcutaneous fat, increased traction-
elated trauma, and higher groin crease bacterial density
ay account in part for the increased incidence of SSI in
bese patients. Altered levels of molecules such as leptin
nd adiponectin in obese patients may also contribute to
roinflammatory states and predisposition to infection.25
he association between end-stage renal disease requiring
ialysis and increased risk for infection is well estab-
ished.26,27 Uremia has been shown to depress the immune
No SSI
,963 (88.9%)
SSI
n  1367 (11.1%) P value
.001a
8.4% 5.9%
72.7% 71.1%
19.0% 23.0%
.001a
83.3% 77.8%
12.7% 16.0%
4.0% 6.1%
4  103 242  104 .001a
7.3% 9.0% .025a
5  5.1 24.0  5.0 .001a
rea nitrogen; COPD, chronic obstructive pulmonary disease;DNR, do not
white blood cell. 10
21
23.
lood uystem, and patients undergoing chronic hemodialysis may
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uch as methicillin-resistant Staphylococcus aureus.28
We found a significant interaction between patient age,
requency of SSI, and 30-day mortality. The adjusted pre-
icted probability of 30-day mortality was lower in the
roup of patients who had SSI compared with those who
id not (1.4% vs 5.8%). This was due to a high rate of early
ostoperative mortality in patients aged 80 and older. In
his subgroup of older patients, the median postoperative
ay of death was 13, compared with 15 for the median
ostoperative day of SSI diagnosis. Thus, a substantial
umber of older patients died of other serious complica-
ions early in the postoperative period, before they could
evelop SSI. The study confirms that older adults represent
high-risk population for open revascularization.
Curiously, prosthetic grafts appeared to be less prone to
SI than vein grafts. Although this finding may represent a
ype 1 statistical error, it is more likely to reflect unmea-
ured confounding variables. For example, the presence of
angrene could not be captured with this dataset. The
resence of gangrene may increase bias toward revascular-
able II. Continued
haracteristic
Adjusted OR
(95% CI)
for SSI
142 (90th percentile) 1.03 (0.82-1.28)
Missing 1.13 (0.73-1.74)
Creatinine (mg/dL)
2.1 or less Reference
2.1 (90th percentile) 0.77 (0.57-1.04)
Missing 0.95 (0.58-1.55)
Albumin (mg/dL)
2.6 or greater Reference
2.6 (10th percentile) 1.04 (0.78-1.37)
Missing 0.97 (0.86-1.10)
perative variables
Type of graft
None (thromboendarterectomy) Reference
Reversed vein 1.39 (1.02-1.88)
In situ vein 1.83 (1.27-2.63)
Prosthetic 1.19 (0.95-1.49)
ASA class
No or mild disturbance Reference
Severe disturbance 1.20 (0.93-1.54)
Life-threatening disturbance or
moribund 1.27 (0.96-1.69)
Blood transfusions
0 units Reference
1-2 units 1.11 (0.94-1.32)
2 units 1.28 (0.98-1.68)
Length of operation
Less than 4 hours Reference
4-6 hours 1.42 (1.24-1.63)a
Greater than 6 hours 1.43 (1.16-1.75)a
Emergency operation
No Reference
Yes 1.21 (0.97-1.51)
SA, American Society of Anesthesiologists; BMI, body mass index;COPD,
hronic obstructive pulmonary disease.
Statistically significant at the P  .05 level.Table II. Multivariate model of predictors of surgical site
infection (SSI) after open lower extremity
revascularization, with adjusted odds ratios (ORs) and
95% confidence intervals (CIs)
Characteristic
Adjusted OR
(95% CI)
for SSI
Demographics
Age
Younger than 50 Reference
50-59 1.05 (0.81-1.35)
60-69 0.84 (0.65-1.08)
70-79 0.83 (0.65-1.07)
80 and older 0.77 (0.59-1.02)
Gender
Male Reference
Female 1.44 (1.28-1.63)a
Preoperative health and comorbidities
Rest pain or gangrene
No Reference
Yes 1.25 (1.11-1.41)a
History of revascularization or
amputation
No Reference
Yes 1.12 (0.99-1.26)
Functional status
Independent Reference
Partially or totally dependent 1.16 (0.99-1.36)
BMI (kg/m2)
18.5 (underweight) 0.79 (0.55-1.12)
18.5 to 24.9 (normal weight) Reference
25 to 29.9 (overweight) 1.28 (1.10-1.49)a
30 or greater (obese) 2.08 (1.78-2.43)a
Diabetes mellitus
No Reference
Yes 1.06 (0.94-1.21)
Dyspnea
No Reference
Yes 1.07 (0.92-1.24)
COPD
No Reference
Yes 1.23 (1.03-1.45)a
Coronary artery disease
No Reference
Yes 1.07 (0.95-1.22)
Hypertension
No Reference
Yes 1.19 (1.00-1.42)
Neurologic disease
No Reference
Yes 1.08 (0.94-1.25)
Dialysis
No Reference
Yes 1.51 (1.08-2.11)a
Steroids
No Reference
Yes 1.26 (0.96-1.64)
Wound infection or open wound
No Reference
Yes 1.08 (0.94-1.23)
Sepsis
No Reference
Yes 1.12 (0.90-1.41)
Preoperative laboratory values
Sodium (mg/dL)
134 (10th percentile) 1.20 (1.02-1.42)azation with autogenous graft but may also increase the risk
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August 2011438 Greenblatt et alof SSI. Additionally, results could not be adjusted for the
number, length, or presence of undermined incisions,
which would be more likely to be associated with autoge-
nous vein harvesting andmay also increase the likelihood of
SSI.
ACS-NSQIP has numerous advantages for the study of
vascular surgery outcomes. ACS-NSQIP includes labora-
tory values as well as information regarding smoking, alco-
hol use, and functional status. These are not available in
administrative databases such as the Healthcare Cost and
Utilization Project Nationwide Inpatient Sample (HCUP-
NIS) and the Medicare database. ACS-NSQIP is based on
prospective medical record extraction and reliably captures
precisely-defined postoperative complications. Complica-
tions not resulting in reoperation or other secondary pro-
cedures are often not recorded in administrative data-
bases.29 Another significant advantage of the ACS-NSQIP
is that it measures 30-day outcomes, not just events that
occur during the surgical hospital stay. In addition to
reviewing the medical record for the hospital stay and clinic
follow-up, the clinical reviewer also searches death regis-
tries and conducts phone interviews. The ability of ACS-
NSQIP to capture 30-day outcomes regardless of hospital
admission status is a major strength compared with other
databases such as HCUP-NIS, which do not monitor
events that occur after hospital discharge. Finally, an addi-
tional benefit of ACS-NSQIP is the multi-institutional data
that is captured. In 2008, the ACS-NSQIP participant use
data file contained data from 211 academic and commu-
nity hospitals nationwide. Findings based on this multi-
institutional data have greater external validity than those
based on the experience of individual specialized academic
centers.
The main limitations of our study are related to the
source of the data. The ACS-NSQIP is a voluntary program
and the 211 participating sites include many academic and
high-volume hospitals. Therefore, the program does not
represent a statistically valid national sample of all hospitals
in the United States. The database contains a wealth of
clinical variables, but essentially no information on patient
socioeconomic status. Hospital identifiers as well as geo-
graphic information are not included in the participant use
Table III. Frequencies and adjusted predicted probabilitie
open lower extremity revascularization and incidence of su
Adverse outcome
All patients
(n  12,330)
frequency
No SSI
(n  10,963)
frequency
(n
f
Prolonged LOS (10 days) 13.4% 12.2%
30-day reoperation 17.8% 15.0%
30-day graft loss 5.4% 4.7%
30-day mortality 2.7% 2.9%
CI, Confidence interval; LOS, length of hospital stay after surgery.
aPredicted probabilities and CIs are adjusted for sex, age, body mass in
revascularization or amputation, critical limb ischemia, coronary artery dise
sepsis, creatinine, sodium, albumin, American Society of Anesthesiologists cfile. Therefore, it is not possible to determine the associa- Oion of hospital procedure volume on surgical outcomes
sing this database. The database also does not include
nformation on surgeon experience or procedure volume.
urrently, ACS-NSQIP only collects information on pro-
edures that are performed in the operating room. Thus,
he program is not an optimal data source for the study of
ercutaneous interventions, which are often performed in
ardiovascular procedure suites. Unlike the Medicare data-
ase, ACS-NSQIP does not provide longitudinal data for
ndividual patients. Therefore, it is not possible to deter-
ine whether the operations in this study were primary or
eoperative.
Despite these limitations, the study has important im-
lications. In this large sample drawn from over 210 aca-
emic and community hospitals nationwide, approximately
ne in nine patients suffered the complication of SSI after
pen surgery for vascular disease, confirming that wound
nfection remains a common cause of morbidity. Further-
ore, SSI was strongly associated with prolonged LOS,
eoperation, and graft failure. We identified several patient
nd operative factors that predict SSI. While some risk
actors such as female gender and obesity are notmodifiable
n the preoperative setting, others represent targets for the
evelopment of interventions that may decrease the inci-
ence of SSI in high-risk patients. Optimizing the periop-
rative medical management of comorbidities such as
OPD, and redoing antibiotics during long operations are
xamples of measures that may decrease the rate of wound
nfections and improve outcomes in this patient popula-
ion.
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